CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 980542593
- Phone
- (877) 237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-26 | Cobb Stuart Chief Scientific Officer | Grant or award · Employee Stock Option (Right to buy) | +42,900 | 42,900 | ||
| 2025-03-26 | Cvijic Christine Mikail President and CFO | Grant or award | +20,300 | 92,643 | ||
| 2025-03-26 | Cvijic Christine Mikail President and CFO | Grant or award · Employee Stock Option (Right to buy) | +122,000 | 122,000 | ||
| 2025-03-26 | Jordan Julie Chief Medical Officer | Grant or award | +8,400 | 8,400 | ||
| 2025-03-26 | Jordan Julie Chief Medical Officer | Grant or award · Employee Stock Option (Right to buy) | +50,300 | 50,300 | ||
| 2025-03-26 | McMinn Rachel Chief Executive Officer | Grant or award | +23,900 | 1,274,259 | ||
| 2025-03-26 | McMinn Rachel Chief Executive Officer | Grant or award · Employee Stock Option (Right to buy) | +143,500 | 143,500 | ||
| 2025-03-13 | Cvijic Christine Mikail President and CFO | Sale 10b5-1 | −4,501 | $16.94 | $76K | 72,343 |
| 2024-11-26 | Samsara BioCapital GP, LLC 10% owner | Purchase | +20,748 | $24.91 | $517K | 1,689,105 |
| 2024-11-26 | Samsara BioCapital GP, LLC 10% owner | Purchase | +10,803 | $26.01 | $281K | 1,699,908 |
| 2024-11-26 | Samsara BioCapital GP, LLC 10% owner | Purchase | +15,219 | $26.73 | $407K | 1,715,127 |
| 2024-11-26 | Samsara BioCapital GP, LLC 10% owner | Purchase | +2,000 | $27.50 | $55K | 1,717,127 |
| 2024-11-22 | Cvijic Christine Mikail President and CFO | Purchase | +24,000 | $20.48 | $491K | 76,844 |
| 2024-11-22 | McMinn Rachel Chief Executive Officer | Purchase | +47,500 | $20.40 | $969K | 1,297,859 |
| 2024-06-14 | Woods Keith Director | Grant or award · Stock Option (Right to Buy) | +7,700 | 7,700 | ||
| 2024-06-14 | Woods Robert Keith Director | Grant or award · Stock Option (Right to Buy) | +7,700 | 7,700 | ||
| 2024-06-14 | PALEKAR ROHAN Director | Grant or award · Stock Option (Right to Buy) | +7,700 | 7,700 | ||
| 2024-06-14 | BAFFI ROBERT Director | Grant or award · Stock Option (Right to Buy) | +7,700 | 7,700 | ||
| 2024-06-14 | Noonberg Sarah B. Director | Grant or award · Stock Option (Right to Buy) | +7,700 | 7,700 | ||
| 2024-06-14 | Freedland Cory S. Director | Grant or award · Stock Option (Right to Buy) | +7,700 | 7,700 |
Page 3 of 8 · 158 trades